Expanding R&D Investment Through 2035
Fostering AI-Driven High-Value Businesses
Full-Scale Shift Toward an "Integrated Solutions Company"

LG Chem will invest 15 trillion won in research and development (R&D) by 2035 and embark on a transformation into an AI-driven high-value materials company. The company aims to move away from a business structure focused on general-purpose chemicals and enhance profitability by fostering semiconductors, mobility and robotics materials, and anticancer drug development as future growth engines.

Dongchun Kim, President of LG Chem, is explaining the strategy for fostering future core businesses such as semiconductors, mobility, and robotics at a town hall meeting on the 22nd. LG Chem

Dongchun Kim, President of LG Chem, is explaining the strategy for fostering future core businesses such as semiconductors, mobility, and robotics at a town hall meeting on the 22nd. LG Chem

View original image

At a town hall meeting on the 22nd, Kim Dongchun, President of LG Chem, stated, "We will strengthen the competitiveness of our existing businesses while focusing our capabilities on future growth sectors to leap forward as a technology-strong converting company."


LG Chem plans to invest a total of 15 trillion won in R&D by 2035, allocating 70% of its R&D resources to the development of semiconductors, mobility, and robotics materials. The company will also focus on securing leading technologies and new AI-based application fields.


In the semiconductor sector, LG Chem aims to strengthen its competitiveness in advanced packaging materials, and to expand its electronic materials business to a scale of 2 trillion won by 2030, based on products such as PID (polyimide insulation materials), DAF (die attach film for semiconductor chips), and CCL (copper-clad laminates for circuit boards). In the mobility and robotics sector, the company will expand its business area beyond electric vehicle materials to include structural materials for robots and precision drive and bonding materials.


For the anticancer drug business, LG Chem plans to enhance its competitiveness by focusing on global clinical trials and partnerships, and to pursue commercialization through technology transfer and mergers and acquisitions (M&A).



LG Chem presented a goal to transform its business model from simple materials supply to that of an "integrated solutions company," which includes co-designing customer product performance and manufacturing processes, with the aim of achieving a double-digit operating margin by 2030.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing